Axsome Therapeutics, Inc. (AXSM)

NGM – Real Time Price. Currency in USD

216.16

+0.39 (0.18%)

Market open: Aug 12, 2026, 10:06 AM EDT

215.35

-0.42 (-0.19%)

Previous after-hours: Aug 11, 2026, 7:52 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

638M

386M

271M

50M

Cost of goods sold

-57M

-41M

-33M

-11M

Gross Profit

582M

344M

238M

39M

Operating expenses (excl. COGS)

-751M

-597M

-421M

-215M

Operating Income

-169M

-252M

-183M

-176M

Non-operating income, total

-14M

-35M

-55M

-11M

Pretax income

-184M

-287M

-238M

-187M

Equity in earnings

Taxes

530K

-85K

-960K

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-183M

-287M

-239M

-187M

Discontinued operations

Net income

-183M

-287M

-239M

-187M

Dilution adjustment

Preferred dividends

Axsome Therapeutics, Inc. (AXSM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Axsome Therapeutics, Inc. (AXSM)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

Axsome Therapeutics, Inc. (AXSM)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Axsome Therapeutics, Inc. (AXSM)

Income Statement (Annual)

Income Statement (Annual)